Provided by Tiger Trade Technology Pte. Ltd.

Praxis Precision Medicines, Inc.

263.55
-14.4700-5.20%
Post-market: 263.550.00000.00%16:43 EDT
Volume:675.59K
Turnover:179.09M
Market Cap:7.34B
PE:-20.49
High:273.96
Open:273.74
Low:260.07
Close:278.02
52wk High:392.70
52wk Low:50.56
Shares:27.85M
Float Shares:24.08M
Volume Ratio:1.52
T/O Rate:2.81%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-12.8634
EPS(LYR):-13.4758
ROE:-38.86%
ROA:-25.65%
PB:5.47
PE(LYR):-19.56

Loading ...

Praxis Precision price target raised to $826 from $810 at BTIG

TIPRANKS
·
Oct 06

Praxis Precision Med is Maintained at Buy by BTIG

Dow Jones
·
Oct 06

Praxis Precision Medicines Grants 3,478 Inducement RSUs to 14 New Employees Under 2024 Plan

Reuters
·
Oct 03

Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Oct 03

Praxis Precision Medicines, Inc. : Jonestrading Raises Target Price to $534 from $441

THOMSON REUTERS
·
Oct 02

Analyst Justin Walsh Reiterates Buy on Praxis as Upgraded Relutrigine Forecast Triples Long-Term Revenue Potential

TIPRANKS
·
Oct 02

Analysts Offer Insights on Healthcare Companies: Praxis Precision Medicines (PRAX), Oruka Therapeutics (ORKA) and Harmony Biosciences Holdings (HRMY)

TIPRANKS
·
Sep 24

Analyst Reiterates Buy on PRAX with Unchanged $582 Price Target Ahead of Key Phase 3 EMERALD Trial for Relutrigine

TIPRANKS
·
Sep 24

Praxis Precision Med Price Target Maintained with a $582.00/Share by Needham

Dow Jones
·
Sep 24

Praxis Precision Medicines Grants RSUs for 11,535 Shares to 66 New Employees Under 2024 Inducement Plan

Reuters
·
Sep 04

Praxis Precision Medicines, Inc. Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Sep 04

Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Sep 04

Movement Alert|Praxis Precision Medicines, Inc. Rises 5.15% in Regular Trading, Trading at $389.76

Market Focus
·
Aug 20

Praxis Precision Medicines Could Be Approaching 'Perfect Trifecta,' Oppenheimer Says

MT Newswires Live
·
Aug 17

Praxis Precision Medicines, Inc. : Raymond James Raises Target Price to $945 from $765

THOMSON REUTERS
·
Aug 17

Praxis Precision Med is Maintained at Equal-Weight by Wells Fargo

Dow Jones
·
Aug 07

Analysts Offer Insights on Healthcare Companies: Viatris (VTRS), Immunocore Holdings (IMCR) and Praxis Precision Medicines (PRAX)

TIPRANKS
·
Aug 07

Praxis Precision price target raised to $514 from $400 at Baird

TIPRANKS
·
Aug 07

Praxis Precision Medicines, Inc. : Deutsche Bank Raises Target Price to $475 from $374

THOMSON REUTERS
·
Aug 07

Definium Therapeutics Q2 Net Loss Widens on Higher Warrant Costs

Reuters
·
Aug 07